Marfan syndrome 

Introduction 

Marfan syndrome

Marfan syndrome is a genetic condition that affects the body's connective tissues. An expert describes the indicators of the conditions and explains how the lack of support and structure from the connective tissue can damage the eyes, the skeleton and the blood vessels. There is currently no cure for Marfan syndrome.

How common is Marfan syndrome?

Although Marfan syndrome is rare, affecting about 1 in 5,000 people, it is one of the most common connective tissue disorders.

Both men and women are equally affected by Marfan syndrome. In around three-quarters of cases, it is inherited from one parent. In the remaining quarter of cases, neither parent has the syndrome.

Marfan syndrome is a disorder of the body's connective tissues. Children usually inherit it from one of their parents.

Connective tissue helps maintain the body's structure and provides support to other tissue and organs.

Some people are only mildly affected by Marfan syndrome, while others develop more serious symptoms. Typical characteristics of Marfan syndrome include:

  • being tall 
  • abnormally long and slender limbs, fingers and toes (arachnodactyly)
  • heart defects
  • lens dislocation – where the lens of the eye falls into an abnormal position

Read more about the symptoms of Marfan syndrome.

What causes Marfan syndrome?

Marfan syndrome is hereditary, which means that it is passed to a child from their affected parent. There is a one in two chance that someone with Marfan syndrome will have a child who also has the syndrome.

A person with Marfan syndrome does not have enough of a protein called fibrillin in their connective tissue. This results in parts of their body being able to stretch abnormally when placed under any kind of stress.

The defective fibrillin gene also causes some bones to grow longer than they should. So someone with Marfan syndrome may be tall because their arms and legs grow longer than normal.

Read more about the causes of Marfan syndrome.

Diagnosing Marfan syndrome

If can be difficult to diagnose Marfan syndrome because the symptoms can vary significantly from person to person.

As the symptoms of Marfan syndrome do not always develop during childhood, the condition may not be identified until the teenage years.

A genetic test can be used to definitively confirm Marfan syndrome by closely studying the affected gene. However, because the gene can mutate (change) in over 1,000 different ways, it is a very time-consuming and expensive process.

Therefore, in most cases, a diagnosis of Marfan syndrome will be based on a thorough physical examination and a detailed assessment of a person's medical and family history.

Read more about how Marfan syndrome is diagnosed.

Treating Marfan syndrome

There is no cure for Marfan syndrome, so treatment focuses on managing the symptoms and reducing the risk of complications.

As Marfan syndrome affects several different parts of the body, treatment involves a number of healthcare professionals working together as a team. Your condition will be closely monitored and treated when complications occur.

The life expectancy of someone with Marfan syndrome may be reduced if the heart and aorta (the body's main artery) are significantly affected.

Read more about the possible treatments for Marfan syndrome.




Last reviewed: 09/05/2012

Next review due: 09/05/2014

Ratings

How helpful is this page?

Average rating

Based on 29 ratings

All ratings

Add your rating

Comments are personal views. Any information they give has not been checked and may not be accurate.

Elizabeth at NHSChoices said on 07 May 2010

Marfan syndrome affects approximately 1 in 5,000 people. Generally, conditions that affect between 1 in 1,000 people and 1 in 10,000 people are classed as rare.

However, Marfan syndrome is more common than a number of other connective tissue conditions - for example, Ehlers-Danlos syndrome (that affects the strength of the skin, joints and connective tissues) is estimated to affect between 1 in 5,000 and 1 in 10,000 people, and osteogenesis imperfecta (that causes brittle bones) affects around 1 in 25,000 people in its most severe form.

Report this content as offensive or unsuitable

Marfan Association UK said on 15 April 2010

Re Government response: we find your first two paragraphs confusing. In the first you state that "MFS is the most common connective tissue disorder". In the second paragraph you state "the condition is rare". It is actually much more common that was thought and the incidence of MFS is known to be between 1 in 3,300 and 1 in 5,000. Since it is, in 75% of cases hereditary, some families have many affected members and many remain undiagnosed. This is why we request improved facilities to enable early and life-saving diagnosis and/or urgent surgery.

Report this content as offensive or unsuitable

Screening and testing

Information about the various screening and testing health checks you may undergo throughout your life